Can Novel Oxygenation Indices Guide the Diagnosis of Acute Respiratory Distress Syndrome

May 21, 2024 updated by: Furkan Tontu, Başakşehir Çam & Sakura City Hospital

New Criteria for Classifying Acute Respiratory Distress Syndrome Severity Using a Machine Learning Approach: Novel Oxygenation and Saturation Indices

This study aims to determine the cut-off values of the new oxygenation indices and further investigate their capabilities in diagnosing ARDS and predicting its severity in ICU. Additionally, the investigators aim to compare these results with conventional oxygenation and saturation indices.

Study Overview

Status

Completed

Detailed Description

Recent studies have shown that mechanical power (MP) values below 17 J/min and driving pressure (DP) values below 15 cmH2O reduce intensive care unit (ICU) mortality. Asar et al. have introduced six new oxygenation indices utilizing MP and DP instead of Pmean (OSI-MPtot, OI-MPtot, OSI-ΔPinsp, OI-ΔPinsp, OSI-MPdyn, OI-MPdyn). They compared the predictive abilities of these new indices for ICU mortality in Covid-ARDS (C-ARDS) patients with conventional oxygenation indices (P/F, SpO2/FiO2, OI, OSI, PaO2/(FiO2xPEEP), and SpO2/FiO2xPEEP). OI-ΔPinsp, OSI-ΔPinsp, and OSI-MPdyn indices exhibited the highest predictive power for ICU mortality. However, cut-off values for the diagnosis and severity determination (mild, moderate, and severe) of ARDS patients have not been investigated.

In this study, our objective is to determine the cut-off values of the new oxygenation indices and further investigate their capabilities in diagnosing ARDS and predicting its severity in ICU. Additionally, the investigators aim to compare these results with conventional oxygenation and saturation indices.

Study Type

Observational

Enrollment (Actual)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Basaksehir Cam Sakura City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients admitted to the intensive care unit of Istanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital with a preliminary diagnosis of ARDS/C-ARDS between June 01, 2012, and February 01, 2024

Description

Inclusion Criteria:

  1. Patients admitted to intensive care units diagnosed with ARDS / C-ARDS according to the Berlin criteria.
  2. Adult patients aged between 18 and 80 years

Exclusion Criteria:

  1. Patients under the age of 18
  2. Pregnant patients
  3. Patients without ARDS
  4. Patients with missing data
  5. Patients transferred to another hospital
  6. Patients discharged from the ICU within 72 hours
  7. Patients receiving extracorporeal membrane oxygenation (ECMO) support.
  8. Patients were on mechanical ventilation for less than 24 hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients diagnosed with Acute Respiratory Distress Syndrome (ARDS) according to Berlin criteria
The oxygenation indexes of the patients will be measured and the effectiveness of these indexes in diagnosing ARDS will be compared.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygenation indices
Time Frame: During 28 days in the intensive care unit
It was aimed to compare the oxygenation indexes of the patients. It will be examined which of these indices is more effective in diagnosing ARDS.
During 28 days in the intensive care unit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Other parameters
Time Frame: During 28 days in the intensive care unit

It was aimed to compare the sequential organ failure assessment scores of the patients.

Score ranges from 0 (best outcome) to 24 (worst outcome) points.

During 28 days in the intensive care unit
acute physiology and chronic health evaluation-II
Time Frame: During 28 days in the intensive care unit

It was aimed to compare the acute physiology and chronic health evaluation-II scores of the patients.

Score ranges from 0 (best outcome) to 71 (worst outcome) points.

During 28 days in the intensive care unit
Charlson comorbidity index scores
Time Frame: During 28 days in the intensive care unit
It was aimed to compare the Charlson comorbidity index scores of the patients. Based on the Charlson comorbidity index score, the severity of comorbidity was categorized into three grades: mild, with Charlson comorbidity index scores of 1-2; moderate, with Charlson comorbidity index scores of 3-4; and severe, with Charlson comorbidity index scores ≥5.
During 28 days in the intensive care unit
Other parameters
Time Frame: During 28 days in the intensive care unit
It was aimed to compare the Charlson comorbidity index of the patients.
During 28 days in the intensive care unit
arterial blood gas parameters
Time Frame: During 28 days in the intensive care unit
It was aimed to compare the pH of the patients.
During 28 days in the intensive care unit
arterial blood gas parameters
Time Frame: During 28 days in the intensive care unit
It was aimed to compare the base excess of the patients.
During 28 days in the intensive care unit
arterial blood gas parameters
Time Frame: During 28 days in the intensive care unit
It was aimed to compare the lactate of the patients.
During 28 days in the intensive care unit
arterial blood gas parameters
Time Frame: During 28 days in the intensive care unit
It was aimed to compare the partial oxygen pressure of the patients.
During 28 days in the intensive care unit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2012

Primary Completion (Actual)

February 1, 2024

Study Completion (Actual)

May 1, 2024

Study Registration Dates

First Submitted

May 9, 2024

First Submitted That Met QC Criteria

May 21, 2024

First Posted (Actual)

May 28, 2024

Study Record Updates

Last Update Posted (Actual)

May 28, 2024

Last Update Submitted That Met QC Criteria

May 21, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Distress Syndrome, Adult

3
Subscribe